Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program
ConditionBreast Neoplasm
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorUniversidad de Granada
About this trial
The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.
Eligibility criteria
Qualifiers
18 years or older
HER2+ breast cancer diagnosis
On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy)
Disqualifiers
Previous diagnosis of cancer
Pregnant
Cardiac pathology
No symptoms or pathology that could be confused with neuropathy or related to diabetes
Trial design
Treatments tested in this trial
- PRESIONA
Treatment groups
25 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov